Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
susceptibility to both nicotine addiction and lung cancer. We will develop specific and accurate camelid antibodies fragments (nanobodies) to examine the distribution of WT and mutant receptor in native conditions
-
, shaping the future of medicine through cutting-edge research. A Postdoctoral Fellowship position is available in the RSP Lab led by Dr. Sklavenitis Pistofidis. The RSP Lab (https://rsplab.org ) leverages
-
Full Time Add to My Favorite Jobs Email this Job Job Summary The Staff Research Associate 3 will support the UC Davis/NIH NeuroMab Facility by performing advanced antibody development, characterization
-
19 Dec 2025 Job Information Organisation/Company Maastricht University (UM) Research Field Chemistry » Analytical chemistry Chemistry » Applied chemistry Engineering » Biomedical engineering
-
for graphene. Engineer antibodies/nanobodies, aptamers and dCas9 to retain target binding after immobilization on graphene/oxo-graphene. Validate engineered molecules in binding assays and after conjugation with
-
Job Description The Department of Medicine: Hematology and Oncology has an outstanding opportunity for a Research Scientist Engineer 3 to join their team. Field of Research Study of the molecular
-
I position is available in the RSP Lab led by Dr. Sklavenitis Pistofidis. The RSP Lab (https://rsplab.org ) leverages advanced multi-omic technologies, coupled with experimental perturbations and
-
Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S) | Portugal | 21 days ago
/FCT/i3S/2312/2025 A call is opened for the position of a PhD holder, for an unfixed term work contract to carry out research duties within the project “PSGL-1 immune checkpoint protein antibody blockade
-
immune disorders with precision and speed. This MLS Trainee/1 role offers the excitement of working with cutting-edge technology and automation, close collaboration with world-renown pathologists and
-
antibodies/nanobodies, aptamers and dCas9 to retain target binding after immobilization on graphene/oxo-graphene. Validate engineered molecules in binding assays and after conjugation with nanomaterials